To ask the Scottish Executive what its position is on the first key message of Final Consensus Statement of the Royal College of Physicians' Consensus Conference on Hepatitis C that the hepatitis C epidemic is a public health crisis.
The Executive agrees with the
Final Consensus Statement that Hepatitis C poses a significant and growing problem. Vigorous, concerted action is needed to address the challenges it presents in relation to both prevention and treatmentand care. Already, therefore, and building on the framework set out in the Scottish Needs Assessment Report, published in August 2000, the Executive has introduced a range of measures, a number of which recognise that the main means of transmission is through injecting drug misuse, including:
allocating over £8 million annually to NHS Boards for action to prevent the spread of bloodborne viruses, including Hepatitis C;
revising the Lord Advocate’s guidelines to permit a substantial increase in the number of needles and syringes, which can be supplied to drug misusers;
issuing a range of information materials to drug services and prisons across Scotland to highlight the risks from injecting, including from Hepatitis C;
investing an additional £34 million over the last three years to expand and improve treatment and rehabilitation services for drug misusers. Allocations to NHS boards for 2004-05 for drug treatment services rose by £2.8 million, to £19.75 million, compared to 2003-04. This recognises that research from both Scotland and England indicates that getting people into treatment for their drug problems leads to significant health gains, reduced use of illegal drugs and injecting, and, in consequence, less risk of infections like Hepatitis C;
issuing Hepatitis C materials for professionals and patients;
funding the establishment of a national clinical database of patients diagnosed with hepatitis to help evaluate the effectiveness of treatment;
giving grant towards the UK Hepatitis C Resource Centre Scotland, which is based in Glasgow and offers support and advice on testing and treatment to those affected by Hepatitis C, and
funding of some £300,000 from 2002 from the Executive’s Effective Interventions Unit for research, which aims to find better and more creative ways of changing behaviour among injecting drug users. eHep
To bring further coherence and impetus to this programme of activity, the Executive will shortly publish an action plan, setting out the action currently in train and the additional measures it proposes, including further materials for health professionals and steps to raise public awareness, with a particular focus on groups most at risk.